Links

Homepage

Stock List

Search by Ticker

News

Login

Eli Lilly And Company (NYSE:LLY)
Stock Analysis

LLY151
▲ 0.36%0.54

Stock Analysis

The following stock analysis is based on 7.8 years of data (i.e. since Oct 31, 2012). All the stock history has been downloaded.

Stock Exchange

Eli Lilly And Company trades on the NYSE exchange in USD dollars.

Sector

It is in the sector.

Current Status of Eli Lilly And Company

It is currently trading at $151.0 ($150.46 the previous day).It pays a 1.84% dividend.

Financials

The next reporting date is in 73 days (2020 10 27).

CNN estimates profits for the upcoming quarter will be $1.72 per share ($5.9B). The current Canada / US exchange rate is 1.3252.



Over the past 12 months, $1452054 worth of shares have been purchased and $808704537 worth of shares have been sold by insiders.

Will This Trend Continue?

The year over year average increase is 12.5% per year assuming steady exponential growth. The actual 5 year average is 13.52. Details on the individual increase in one year intervals is provided below.

Past PerformanceAverage PricePercent Change
1 year132.8161209523815.7+ Above Average
2 year114.7478884462236.4+ Above Average
3 year84.1190376569046.2- Below Average
4 year79.2450202429150.2- Below Average
5 year79.0496212121219.1- Below Average
Eli Lilly And Company is projected by analysts to get to $175.00 within the next 12 months (15.9%), but preticted targets range from as high as $190.00 (25.8%) and as low as $148(-2%).

Risk

The worst drop it has had in recent years is -26.7%. It has a shape to the stock curve, which means

Stock shape test

DAYS AG0PRICE
10162.65DROPPING
30166.75DROPPING
60143.71RISING
150129.38RISING
365110.23RISING
80085.93RISING
120081.7RISING
160070.62RISING
200071.88DROPPING


With an average increase of 12.5% year over year, if Eli Lilly And Company is bought at the worst time, Stockmarketizer analysts estimate it will take 25.6 months before the stock will recover to the original purchase price. The P/E value is 24.55.

Tradingview BuySell Widget

Yahoo News Feed

2 Forever Pharma Stocks to Buy Now

Fri, 14 Aug 2020 11:37:00 Only one of these stocks has performed well this year, but both are worth buying and holding over the long term.... Read Full Article

Eli Lilly, Novartis Have Most Valuable Pipeline Drugs

Thu, 13 Aug 2020 20:03:03 Chart shows net present value and forecasted 2026 sales for 10 leading treatments Continue reading...... Read Full Article

Eli Lilly, Innovent’s TYVYT Expanded Use Application Accepted In China

Wed, 12 Aug 2020 13:39:43 Eli Lilly (LLY) and Innovent Biologics have announced that the National Medical Products Administration (NMPA) of China has accepted the supplemental New Drug Application (sNDA) for TYVYT (sintilimab injection) in combination with Gemzar (gemcitabine) and platinum as first-line therapy in ...... Read Full Article

Coronavirus update: Kodak federal loan in jeopardy; Gilead seeks approval of remdesivir

Mon, 10 Aug 2020 16:45:36 Top stories about how the coronavirus pandemic is affecting business around the world.... Read Full Article

Omeros Reports Coronavirus Treatment Success; Stock Soars

Mon, 10 Aug 2020 13:01:23 Small Omeros on Monday reported success with a test of its corononavirus treatment, saying it helped the recovery of six patients severely ill with Covid-19.... Read Full Article

Eli Lilly, Innovent Deliver Encouraging Lung Cancer Data For Sintilimab

Mon, 10 Aug 2020 07:02:46 Eli Lilly (LLY) and Innovent Biologics have announced encouraging interim analysis data from ORIENT-11 at the virtual IASLC World Conference on Lung Cancer (WCLC) 2020.The randomized, double-blind, Phase 3 clinical trial of 397 patients assessed TYVYT (sintilimab injection) with ALIMTA (pemetrexed) and ...... Read Full Article

Eli Lilly and Company (NYSE:LLY) Looks Interesting, And Itand's About To Pay A Dividend

Sat, 08 Aug 2020 14:11:42 Regular readers will know that we love our dividends at Simply Wall St, which is why itand's exciting to see Eli Lilly...... Read Full Article

Pharma ETFs Soar on Robust Q2 Earnings

Fri, 07 Aug 2020 16:45:04 Total earnings of 66.4% of the healthcare market capitalization that has reported so far are up 4.4% on revenue growth of 4%.... Read Full Article

Pharma Stock Roundup: ABBV, MRK Q2 Earnings andand Coronavirus Updates in Focus

Fri, 07 Aug 2020 15:30:03 Sanofi (SNY)/Glaxo (GSK) and JandJ (JNJ) sign deals with U.S. government for coronavirus vaccine candidate. Several drugmakers announce second-quarter results.... Read Full Article

The Zacks Analyst Blog Highlights: Apple, Mastercard, Eli Lilly, PetroChina and Anheuser-Busch InBev

Fri, 07 Aug 2020 14:02:02 The Zacks Analyst Blog Highlights: Apple, Mastercard, Eli Lilly, PetroChina and Anheuser-Busch InBev... Read Full Article

NIH to test remdesivir with Merck KGaAand's interferon therapy as a COVID-19 treatment

Fri, 07 Aug 2020 13:11:00 The National Institutes of Health said it will conduct a randomized, controlled clinical trial testing a combination of Gilead Sciences Inc.and's remdesivir with Merck KGaAand's interferon beta-1a as a treatment for COVID-19 patients. The study plans to enroll 1,000 ...... Read Full Article

‘We need to make sure that the science and safety is there’ so people can trust the vaccine: doctor

Thu, 06 Aug 2020 20:31:27 The conversation around pricing vaccinations and distribution is ramping up as more pharmaceuticals announce positive test results. Dr. Rob Davidson, a West Michigan ER doctor and the Executive Director of the Committee to Protect Medicare, joins The Final Round panel ...... Read Full Article

Early Sales of Eli Lillyand's Migraine Drug Disappoint

Thu, 06 Aug 2020 17:42:51 The company is confident Reyvow will reach $13 billion by 2027 Continue reading...... Read Full Article

Top Stock Reports for Apple, Mastercard and Eli Lilly

Thu, 06 Aug 2020 17:33:05 Top Stock Reports for Apple, Mastercard and Eli Lilly... Read Full Article

The Zacks Analyst Blog Highlights: Eli Lilly, Moderna, Pfizer, Sanofi, GlaxoSmithKline and BioNTech

Wed, 05 Aug 2020 14:06:02 The Zacks Analyst Blog Highlights: Eli Lilly, Moderna, Pfizer, Sanofi, GlaxoSmithKline and BioNTech... Read Full Article

Empagliflozin meets primary endpoint in reducing risk of cardiovascular death or hospitalization for heart failure in Phase III trial in adults with and without diabetes

Wed, 05 Aug 2020 12:00:00 * Empagliflozin significantly reduced the risk of cardiovascular death or hospitalization for heart failure versus placebo in the EMPEROR-Reduced heart failure trial. The study evaluated adults with heart failure with reduced ejection fraction * Treatment of heart failure is an important unmet ...... Read Full Article

NIH to test Lillyand's experimental monoclonal antibody treatment in mild and moderate COVID-19 cases

Wed, 05 Aug 2020 11:58:00 Shares of Eli Lilly and Co. gained 0.6% in premarket trading on Wednesday, the day after the National Institutes of Health said it plans to study whether several experimental monoclonal antibodies can treat hospitalized COVID-19 patients. The first therapy to be ...... Read Full Article

Eli Lillyand's COVID-19 Treatment Candidate Will Be the First Tested in NIHand's Phase 3 Study

Tue, 04 Aug 2020 22:27:00 The National Institutes of Health is starting a head-to-head trial of several antibody treatment candidates.... Read Full Article

Incyte Earnings Soar 65%, Easily Beating Views

Tue, 04 Aug 2020 20:11:01 Incyte earnings and revenue rose much more than expected. The biotech reaffirmed guidance. INCY stock was not yet active early Tuesday.... Read Full Article

Trending Market News Tuesday: Facebook, Eli Lilly, Activision

Tue, 04 Aug 2020 19:15:00 Activision Blizzard employees shared an internal document documenting low pay across different sectors of the company.... Read Full Article
<